Dacula, Sittie Alisha A.
HRN: 21-57-61 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
AMPICILLIN 250MG (VIAL)
08/19/2022
08/26/2022
IVTT
150mg
Q12h
Psnb
Waiting Final Action
08/19/2022
CEFOTAXIME 500MG (VIAL)
08/19/2022
08/26/2022
IVTT
150mg
Q12
Psnb
Waiting Final Action
08/21/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
08/21/2022
08/31/2022
IV
16mg
Q48hrs
NEC
Waiting Final Action